Susan Serrano
Sr. Director Market Access Intellia Therapeutics
Seminars
Thursday 26th March 2026
Starting With the End in Mind to Optimize Gene Therapy Development for Long-Term Impact
9:30 am
- Designing clinical trials and programs with commercialization and patient access in mind from the start
- Defining the right target patient and unmet need to build a strong, scalable value proposition
- Maximizing long-term benefits by prioritizing early decisions on formulation, administration, and cost reduction
